Types and Structure of Complications, and Causes of Mortality with Different Combinations of Immunosuppressants in Patients of Undergoing Organ Transplantation-Reference-Cited by-同舟云学术

Types and Structure of Complications, and Causes of Mortality with Different Combinations of Immunosuppressants in Patients of Undergoing Organ Transplantation

Published:2017-09-10 Issue:Issue 2 Volume:1 Page:61
ISSN:1694-7886
Container-title:Heart, Vessels and Transplantation
language:
Short-container-title:HVT

Author:

Ashimov Zhamalbek,Gaibyldaev Zhanybek

Abstract

We aimed to retrospectively analyze morbidity and mortality in recipients of kidney and liver transplant receiving immunosuppressive therapy (tacrolimus and cyclosporine with mycophenolate mofetil and mycophenolic acid). Overall, 228 patients who underwent kidney and liver transplantation were included in the study. The overall graft survival of patients who underwent kidney and liver transplantation from 1999 to 2017 was 84.2%. Combinations including cyclosporine, were associated with high rate of complications acute rejection, CMV and candida infections as compared to tacrolimus. The most unfavorable in terms of mortality was combination of cyclosporine – mycophenolate mofetil.

Publisher

Center for Scientific Research and Development of Education

Subject

General Medicine

Reference16 articles.

1. Danovitch GМ. Handbook of Kidney Transplantation. 5th ed. Philadelphia (PA): Lippincott Williams&Wilkins; c2009. 471 p.

2. Moisiuk IG, Stoliarevich ЕS, Tomilina NА. Disease of kidney transplant. In: Mukhin NA, eds. Nephrology: national manual. Мoscow: GEOTAR-Media; 2009: 588.

3. Sigitova ОN. Chronic renal disease and chronic renal failure: current approaches to terms, classification and diagnosis. The Bulletin of Contemporary Clinical Medicine 2008: 1; 83-8.

4. Kalble T, Alcaraz A, Budde K, Humke U, Karam G, Lucan M, Nicita G, Susal G. Guidelines on renal transplantation. European Association of Urology, 2010. Available at: URL: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Renal-Transplantation-2010.pdf (Accessed 26.08.2017).

5. Yagudina RI, Kulikov АL., Nguen Т. The definition of "threshold willingness-to-pay»: In Russia, In Europe Countries and in CIS countries. Modern pharmacoeconomics and pharmacoepidemiology 2011; 4: 7-13.